In a small pilot trial of 10 adults with migraine, participants reported fewer attacks and less severe pain during the two weeks following low-dose oral psilocybin. A separate large survey also found an association between lifetime psychedelic use and lower rates of frequent bad headaches, though neither study proves psilocybin prevents migraines. Key takeaways Reduced […]
In a small open-label pilot of five adults with fibromyalgia, psilocybin-assisted therapy was reported to be safe and well tolerated, with no serious adverse events. Several participants showed clinically meaningful reductions in pain severity and related symptoms at one month. These are very early findings from a single small trial. Key takeaways No serious adverse […]
A 2025 focus article published in the Journal of Pain proposes that psilocybin could act as a “psychophysical adaptogen” in chronic pain rehabilitation, potentially loosening what the authors call self-pain enmeshment and reducing psychological barriers to exercise engagement. This is a theoretical framework, not a clinical trial. Key takeaways Identity and pain are intertwined. The […]
A clinical review published in June 2025 through PubMed takes a careful, critical look at the existing literature on psilocybin and other classic psychedelics as potential tools for addressing chronic pain. Rather than offering a verdict, the review maps the current landscape honestly, covering the neuroscience, the safety profile, the known drug interactions, and practical […]
A new study has found that psilocybin, the active compound in psilocybin mushrooms, appears to reset the brain’s pain-processing networks and enhance the efficacy of conventional painkillers through identifiable neurobiological mechanisms. The findings point toward a meaningful role for psilocybin in the future of pain medicine, and they add neurological detail to a growing body […]
A team at Penn Medicine has traced the specific serotonin receptor pathway through which psilocybin produces its antidepressant effects, and they found those effects persisting six months after a single dose. The findings point toward a concrete neurological mechanism, moving the conversation about psilocybin therapy from observed outcomes toward a clearer understanding of how and […]